AnaptysBio, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 25.6M | 108.2M | 76.3M | 22.3M | 27.8M | 43.1M | 30.0M | 11.0M |
| Cost of Goods Sold | 610K | -108.0M | 31.4M | 37.8M | 41.2M | 42.6M | 42.2M | 42.0M |
| Gross Profit | 24.9M | 216.2M | 44.9M | -15.6M | -13.4M | 524K | -12.2M | -31.0M |
| R&D Expenses | 33.9M | 25.6M | 31.4M | 37.8M | 41.2M | 42.6M | 42.2M | 42.0M |
| Operating Expenses | 59.6M | 149.3M | 10.2M | 10.6M | 14.1M | 10.2M | 10.6M | 9.3M |
| Operating Income | -34.6M | 66.9M | 34.7M | -26.2M | -27.5M | -9.7M | -22.8M | -40.3M |
| Other Income / Gains | -18.2M | -17.2M | -19.6M | -12.4M | -11.7M | -12.1M | -10.1M | -6.3M |
| Net Income | -52.9M | 49.6M | 15.1M | -38.6M | -39.3M | -21.8M | -32.9M | -46.7M |
| EPS (Diluted) | -1.84 | 1.79 | 0.54 | -1.34 | -1.28 | -0.77 | -1.14 | -1.71 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.976 | 1.998 | 0.588 | -0.699 | -0.483 | 0.012 | -0.406 | -2.828 |
| General And Administrative Expenses | 26.2M | 15.8M | 10.2M | 10.6M | 14.1M | 10.2M | 10.6M | 9.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 26.2M | 15.8M | 10.2M | 10.6M | 14.1M | 10.2M | 10.6M | 9.3M |
| Other Expenses | -480K | 108.0M | -31.4M | -37.8M | -41.2M | -42.6M | -42.2M | -42.0M |
| Cost And Expenses | 60.2M | 41.3M | 41.6M | 48.4M | 55.3M | 52.8M | 52.8M | 51.3M |
| Interest Income | 2.7M | 2.5M | 2.9M | 3.7M | 4.4M | 5.3M | 5.3M | 4.6M |
| Interest Expense | 20.9M | 19.7M | 22.5M | 19.6M | 18.1M | 17.4M | 15.4M | 11.0M |
| Depreciation And Amortization | 610K | 606K | 610K | 601K | 606K | 601K | 596K | 595K |
| Ebitda | -31.4M | 70.0M | 38.2M | -18.4M | -20.6M | -3.8M | -16.8M | -35.1M |
| Ebitdaratio | -1.228 | 0.647 | 0.501 | -0.826 | -0.742 | -0.088 | -0.561 | -3.20 |
| Operating Income Ratio | -1.355 | 0.618 | 0.455 | -1.175 | -0.992 | -0.224 | -0.758 | -3.675 |
| Income Before Tax | -52.8M | 49.7M | 15.1M | -38.6M | -39.3M | -21.8M | -32.9M | -46.7M |
| Income Before Tax Ratio | -2.068 | 0.459 | 0.198 | -1.733 | -1.415 | -0.505 | -1.094 | -4.252 |
| Income Tax Expense | 40K | 81K | 0 | 39K | 44K | -6K | 0 | 9K |
| Net Income Ratio | -2.069 | 0.458 | 0.198 | -1.735 | -1.416 | -0.505 | -1.094 | -4.253 |
| Epsdiluted | -1.84 | 1.58 | 0.52 | -1.34 | -1.28 | -0.77 | -1.14 | -1.71 |
| Weighted Average Shs Out | 28.7M | 27.8M | 29.1M | 28.8M | 30.6M | 30.4M | 28.8M | 27.4M |
| Weighted Average Shs Out Dil | 28.7M | 31.3M | 29.0M | 28.8M | 30.6M | 30.4M | 28.9M | 27.4M |